{"id":108337,"date":"2026-03-14T11:37:58","date_gmt":"2026-03-14T14:37:58","guid":{"rendered":"https:\/\/med.estrategia.com\/portal\/?p=108337"},"modified":"2026-03-15T18:31:57","modified_gmt":"2026-03-15T21:31:57","slug":"resumo-do-questionario-findrisc-criterios-e-mais","status":"publish","type":"post","link":"https:\/\/med.estrategia.com\/portal\/conteudos-gratis\/exames\/resumo-do-questionario-findrisc-criterios-e-mais\/","title":{"rendered":"Resumo do Question\u00e1rio FINDRISC: crit\u00e9rios e mais!"},"content":{"rendered":"<p><strong>Ol&aacute;, querido doutor e doutora!<\/strong> O <strong>Finnish Diabetes Risk Score (FINDRISC)<\/strong> &eacute; um instrumento cl&iacute;nico utilizado para estimar o risco de desenvolvimento de <strong>diabetes mellitus tipo 2<\/strong> por meio da avalia&ccedil;&atilde;o de fatores de risco cl&iacute;nicos e comportamentais. Sua aplica&ccedil;&atilde;o &eacute; simples, n&atilde;o invasiva e amplamente utilizada em contextos de rastreamento populacional e aten&ccedil;&atilde;o prim&aacute;ria.<p><em>O escore total do FINDRISC varia de 0 a 26 pontos e permite estimar o risco de desenvolvimento de diabetes tipo 2 nos anos subsequentes.<\/em><\/p><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_79_2 counter-hierarchy ez-toc-counter ez-toc-transparent ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\"><p class=\"ez-toc-title\" style=\"cursor:inherit\">Navegue pelo conte\u00fado<\/p>\n<\/div><nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/med.estrategia.com\/portal\/conteudos-gratis\/exames\/resumo-do-questionario-findrisc-criterios-e-mais\/#O-que-e-o-Questionario-FINDRISC\" >O que &eacute; o Question&aacute;rio FINDRISC&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/med.estrategia.com\/portal\/conteudos-gratis\/exames\/resumo-do-questionario-findrisc-criterios-e-mais\/#Estrutura-do-Questionario-FINDRISC\" >Estrutura do Question&aacute;rio FINDRISC&nbsp;&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/med.estrategia.com\/portal\/conteudos-gratis\/exames\/resumo-do-questionario-findrisc-criterios-e-mais\/#Sistema-de-Pontuacao-e-interpretacao\" >Sistema de Pontua&ccedil;&atilde;o e interpreta&ccedil;&atilde;o<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/med.estrategia.com\/portal\/conteudos-gratis\/exames\/resumo-do-questionario-findrisc-criterios-e-mais\/#Limitacoes-do-Questionario\" >Limita&ccedil;&otilde;es do Question&aacute;rio<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/med.estrategia.com\/portal\/conteudos-gratis\/exames\/resumo-do-questionario-findrisc-criterios-e-mais\/#Veja-tambem\" >Veja tamb&eacute;m<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\" id=\"h-o-que-e-o-questionario-findrisc-nbsp\"><span class=\"ez-toc-section\" id=\"O-que-e-o-Questionario-FINDRISC\"><\/span>O que &eacute; o Question&aacute;rio FINDRISC&nbsp;<span class=\"ez-toc-section-end\"><\/span><\/h2><p>O <strong>Finnish Diabetes Risk Score (FINDRISC)<\/strong> &eacute; um question&aacute;rio validado utilizado para estimar o <strong>risco de desenvolvimento de diabetes mellitus tipo 2 em adultos<\/strong>. Trata-se de um instrumento de triagem <strong>n&atilde;o invasivo e de f&aacute;cil aplica&ccedil;&atilde;o<\/strong>, amplamente empregado em contextos cl&iacute;nicos e em programas de rastreamento populacional para identificar indiv&iacute;duos com maior probabilidade de desenvolver a doen&ccedil;a nos anos seguintes.<\/p><h2 class=\"wp-block-heading\" id=\"h-estrutura-do-questionario-findrisc-nbsp-nbsp\"><span class=\"ez-toc-section\" id=\"Estrutura-do-Questionario-FINDRISC\"><\/span>Estrutura do Question&aacute;rio FINDRISC&nbsp;&nbsp;<span class=\"ez-toc-section-end\"><\/span><\/h2><p>O <strong>Finnish Diabetes Risk Score (FINDRISC)<\/strong> &eacute; composto por <strong>oito perguntas objetivas<\/strong> relacionadas a fatores cl&iacute;nicos e comportamentais associados ao risco de desenvolvimento de <strong>diabetes mellitus tipo 2<\/strong>.&nbsp;<\/p><p>Cada item possui alternativas com pontua&ccedil;&atilde;o espec&iacute;fica, e a soma das respostas gera um escore total entre <strong>0 e 26 pontos<\/strong>, utilizado para estimar o risco futuro da doen&ccedil;a. Trata-se de um instrumento <strong>n&atilde;o invasivo, simples e aplic&aacute;vel em contextos cl&iacute;nicos e em programas de rastreamento populacional<\/strong>.<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Vari&aacute;vel<\/th><th class=\"has-text-align-center\" data-align=\"center\">Categoria<\/th><th class=\"has-text-align-center\" data-align=\"center\">Pontua&ccedil;&atilde;o<\/th><\/tr><\/thead><tbody><tr><td><strong>Idade<\/strong><\/td><td class=\"has-text-align-center\" data-align=\"center\">&lt; 45 anos<\/td><td class=\"has-text-align-center\" data-align=\"center\">0<\/td><\/tr><tr><td><\/td><td class=\"has-text-align-center\" data-align=\"center\">45 a 54 anos<\/td><td class=\"has-text-align-center\" data-align=\"center\">2<\/td><\/tr><tr><td><\/td><td class=\"has-text-align-center\" data-align=\"center\">55 a 64 anos<\/td><td class=\"has-text-align-center\" data-align=\"center\">3<\/td><\/tr><tr><td><\/td><td class=\"has-text-align-center\" data-align=\"center\">&gt; 64 anos<\/td><td class=\"has-text-align-center\" data-align=\"center\">4<\/td><\/tr><tr><td><strong>&Iacute;ndice de massa corporal (IMC)<\/strong><\/td><td class=\"has-text-align-center\" data-align=\"center\">&lt; 25 kg\/m&sup2;<\/td><td class=\"has-text-align-center\" data-align=\"center\">0<\/td><\/tr><tr><td><\/td><td class=\"has-text-align-center\" data-align=\"center\">25 a 29,9 kg\/m&sup2;<\/td><td class=\"has-text-align-center\" data-align=\"center\">1<\/td><\/tr><tr><td><\/td><td class=\"has-text-align-center\" data-align=\"center\">&ge; 30 kg\/m&sup2;<\/td><td class=\"has-text-align-center\" data-align=\"center\">3<\/td><\/tr><tr><td><strong>Circunfer&ecirc;ncia da cintura<\/strong><\/td><td class=\"has-text-align-center\" data-align=\"center\"><strong>Homens:<\/strong> &lt; 94 cm<\/td><td class=\"has-text-align-center\" data-align=\"center\">0<\/td><\/tr><tr><td><\/td><td class=\"has-text-align-center\" data-align=\"center\"><strong>Homens:<\/strong> 94 a &lt; 102 cm<\/td><td class=\"has-text-align-center\" data-align=\"center\">3<\/td><\/tr><tr><td><\/td><td class=\"has-text-align-center\" data-align=\"center\"><strong>Homens:<\/strong> &ge; 102 cm<\/td><td class=\"has-text-align-center\" data-align=\"center\">4<\/td><\/tr><tr><td><\/td><td class=\"has-text-align-center\" data-align=\"center\"><strong>Mulheres:<\/strong> &lt; 80 cm<\/td><td class=\"has-text-align-center\" data-align=\"center\">0<\/td><\/tr><tr><td><\/td><td class=\"has-text-align-center\" data-align=\"center\"><strong>Mulheres:<\/strong> 80 a &lt; 88 cm<\/td><td class=\"has-text-align-center\" data-align=\"center\">3<\/td><\/tr><tr><td><\/td><td class=\"has-text-align-center\" data-align=\"center\"><strong>Mulheres:<\/strong> &ge; 88 cm<\/td><td class=\"has-text-align-center\" data-align=\"center\">4<\/td><\/tr><tr><td><strong>Uso de medica&ccedil;&atilde;o para press&atilde;o arterial<\/strong><\/td><td class=\"has-text-align-center\" data-align=\"center\">N&atilde;o<\/td><td class=\"has-text-align-center\" data-align=\"center\">0<\/td><\/tr><tr><td><\/td><td class=\"has-text-align-center\" data-align=\"center\">Sim<\/td><td class=\"has-text-align-center\" data-align=\"center\">2<\/td><\/tr><tr><td><strong>Hist&oacute;rico de glicemia elevada<\/strong><\/td><td class=\"has-text-align-center\" data-align=\"center\">N&atilde;o<\/td><td class=\"has-text-align-center\" data-align=\"center\">0<\/td><\/tr><tr><td><\/td><td class=\"has-text-align-center\" data-align=\"center\">Sim<\/td><td class=\"has-text-align-center\" data-align=\"center\">5<\/td><\/tr><tr><td><strong>Atividade f&iacute;sica<\/strong><\/td><td class=\"has-text-align-center\" data-align=\"center\">&ge; 4 horas por semana<\/td><td class=\"has-text-align-center\" data-align=\"center\">0<\/td><\/tr><tr><td><\/td><td class=\"has-text-align-center\" data-align=\"center\">&lt; 4 horas por semana<\/td><td class=\"has-text-align-center\" data-align=\"center\">2<\/td><\/tr><tr><td><strong>Consumo di&aacute;rio de frutas, vegetais ou frutas vermelhas<\/strong><\/td><td class=\"has-text-align-center\" data-align=\"center\">Sim<\/td><td class=\"has-text-align-center\" data-align=\"center\">0<\/td><\/tr><tr><td><\/td><td class=\"has-text-align-center\" data-align=\"center\">N&atilde;o<\/td><td class=\"has-text-align-center\" data-align=\"center\">1<\/td><\/tr><tr><td><strong>Hist&oacute;ria familiar de diabetes<\/strong><\/td><td class=\"has-text-align-center\" data-align=\"center\">N&atilde;o<\/td><td class=\"has-text-align-center\" data-align=\"center\">0<\/td><\/tr><tr><td><\/td><td class=\"has-text-align-center\" data-align=\"center\">Parente de segundo grau<\/td><td class=\"has-text-align-center\" data-align=\"center\">3<\/td><\/tr><tr><td><\/td><td class=\"has-text-align-center\" data-align=\"center\">Parente de primeiro grau<\/td><td class=\"has-text-align-center\" data-align=\"center\">5<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\" id=\"h-sistema-de-pontuacao-e-interpretacao\"><span class=\"ez-toc-section\" id=\"Sistema-de-Pontuacao-e-interpretacao\"><\/span>Sistema de Pontua&ccedil;&atilde;o e interpreta&ccedil;&atilde;o<span class=\"ez-toc-section-end\"><\/span><\/h2><p>O <strong>Finnish Diabetes Risk Score (FINDRISC)<\/strong> &eacute; calculado a partir da soma das pontua&ccedil;&otilde;es atribu&iacute;das a <strong>oito vari&aacute;veis cl&iacute;nicas e comportamentais<\/strong> associadas ao risco de desenvolvimento de <strong>diabetes mellitus tipo 2<\/strong>. Cada vari&aacute;vel possui categorias com pontua&ccedil;&atilde;o definida, e o escore total pode variar de <strong>0 a 26 pontos<\/strong>. Valores mais elevados indicam <strong>maior probabilidade de desenvolvimento da doen&ccedil;a ao longo dos anos subsequentes<\/strong>.<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th class=\"has-text-align-center\" data-align=\"center\">Pontua&ccedil;&atilde;o Total<\/th><th class=\"has-text-align-center\" data-align=\"center\">Classifica&ccedil;&atilde;o do Risco<\/th><th>Risco Estimado em 10 anos<\/th><\/tr><\/thead><tbody><tr><td class=\"has-text-align-center\" data-align=\"center\">0 a 3<\/td><td class=\"has-text-align-center\" data-align=\"center\"><strong>Muito baixo<\/strong><\/td><td>&bull; Homens 0,3% <br>&bull; Mulheres 0,1%<\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\">4 a 8<\/td><td class=\"has-text-align-center\" data-align=\"center\"><strong>Baixo<\/strong><\/td><td>&bull; Homens 0,8% <br>&bull; Mulheres 0,4%<\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\">9 a 12<\/td><td class=\"has-text-align-center\" data-align=\"center\"><strong>Moderado<\/strong><\/td><td>&bull; Homens 2,6% <br>&bull; Mulheres 2,2%<\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\">13 a 20<\/td><td class=\"has-text-align-center\" data-align=\"center\"><strong>Alto<\/strong><\/td><td>&bull; Homens 23,1% <br>&bull; Mulheres 14,1%<\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\">&ge; 21<\/td><td class=\"has-text-align-center\" data-align=\"center\"><strong>Muito alto<\/strong><\/td><td>Aproximadamente 50%<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\" id=\"h-limitacoes-do-questionario\"><span class=\"ez-toc-section\" id=\"Limitacoes-do-Questionario\"><\/span>Limita&ccedil;&otilde;es do Question&aacute;rio<span class=\"ez-toc-section-end\"><\/span><\/h2><p>Embora o <strong>Finnish Diabetes Risk Score (FINDRISC)<\/strong> seja amplamente utilizado como ferramenta de triagem para estimar o risco de <strong>diabetes mellitus tipo 2<\/strong>, algumas limita&ccedil;&otilde;es devem ser consideradas na interpreta&ccedil;&atilde;o dos resultados e na sua aplica&ccedil;&atilde;o em diferentes contextos populacionais.<\/p><p>O desempenho do question&aacute;rio apresenta <strong>sensibilidade e especificidade moderadas<\/strong>, com &aacute;rea sob a curva variando aproximadamente entre <strong>0,69 e 0,82<\/strong> em diferentes estudos. Essa varia&ccedil;&atilde;o depende do <strong>ponto de corte utilizado<\/strong> e das caracter&iacute;sticas da popula&ccedil;&atilde;o avaliada, podendo ocorrer <strong>falsos positivos e falsos negativos<\/strong>, principalmente em cen&aacute;rios com preval&ecirc;ncia diferente daquela observada na popula&ccedil;&atilde;o original em que o instrumento foi desenvolvido.<\/p><p>Alguns itens do question&aacute;rio baseiam-se em <strong>informa&ccedil;&otilde;es fornecidas pelo pr&oacute;prio paciente<\/strong>, como n&iacute;vel de atividade f&iacute;sica e frequ&ecirc;ncia de consumo de frutas e vegetais. Esse tipo de informa&ccedil;&atilde;o pode sofrer influ&ecirc;ncia de <strong>vi&eacute;s de mem&oacute;ria ou desejabilidade social<\/strong>, o que pode comprometer a precis&atilde;o das respostas e impactar a estimativa de risco.<\/p><p>A acur&aacute;cia do FINDRISC pode ser <strong>menor em determinados grupos populacionais<\/strong>, incluindo idosos, minorias &eacute;tnicas e popula&ccedil;&otilde;es fora do contexto europeu. Estudos realizados em diferentes pa&iacute;ses demonstraram que a ferramenta pode exigir <strong>processos de valida&ccedil;&atilde;o e recalibra&ccedil;&atilde;o local<\/strong> para manter desempenho adequado em diferentes cen&aacute;rios epidemiol&oacute;gicos.<\/p><h3 class=\"wp-block-heading\" id=\"h-ausencia-de-marcadores-laboratoriais-ou-geneticos\">Aus&ecirc;ncia de marcadores laboratoriais ou gen&eacute;ticos<\/h3><p>O escore baseia-se exclusivamente em <strong>vari&aacute;veis cl&iacute;nicas e comportamentais<\/strong>, n&atilde;o incluindo <strong>marcadores bioqu&iacute;micos ou gen&eacute;ticos<\/strong> que poderiam aumentar a capacidade preditiva. A incorpora&ccedil;&atilde;o de par&acirc;metros laboratoriais em modelos combinados pode melhorar a acur&aacute;cia diagn&oacute;stica, sobretudo em indiv&iacute;duos com risco intermedi&aacute;rio.<\/p><h3 class=\"wp-block-heading\" id=\"h-desempenho-limitado-para-identificacao-de-pre-diabetes\">Desempenho limitado para identifica&ccedil;&atilde;o de pr&eacute;-diabetes<\/h3><p>A capacidade do FINDRISC para identificar <strong>altera&ccedil;&otilde;es glic&ecirc;micas iniciais<\/strong>, como pr&eacute;-diabetes ou disglicemia, tende a ser inferior quando comparada &agrave; sua capacidade de prever diabetes estabelecido. Estudos demonstram <strong>menor sensibilidade e menor &aacute;rea sob a curva<\/strong> para esse objetivo espec&iacute;fico.<\/p><p><strong><em>Venha fazer parte da maior plataforma de Medicina do Brasil! O Estrat&eacute;gia MED possui os materiais mais atualizados e cursos ministrados por especialistas na &aacute;rea. N&atilde;o perca a oportunidade de elevar seus estudos, inscreva-se agora e comece a construir um caminho de excel&ecirc;ncia na medicina!<\/em><\/strong>&nbsp;<\/p><h2 class=\"wp-block-heading\" id=\"h-veja-tambem\"><span class=\"ez-toc-section\" id=\"Veja-tambem\"><\/span>Veja tamb&eacute;m<span class=\"ez-toc-section-end\"><\/span><\/h2><ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/med.estrategia.com\/portal\/conteudos-gratis\/doencas\/resumo-de-diabetes-tipo-lada-causas-diagnostico-e-mais\/\">Resumo de Diabetes tipo LADA: causas, diagn&oacute;stico e mais!<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/med.estrategia.com\/portal\/conteudos-gratis\/doencas\/resumo-de-saude-bucal-em-pessoas-com-diabetes\/\">Resumo de Sa&uacute;de Bucal em Pessoas com Diabetes<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/med.estrategia.com\/portal\/conteudos-gratis\/doencas\/resumo-de-diabetes-tipo-5-definicao-epidemiologia-e-mais\/\">Resumo de Diabetes Tipo 5: defini&ccedil;&atilde;o, epidemiologia e mais!<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/med.estrategia.com\/portal\/conteudos-gratis\/doencas\/resumo-sobre-diabetes-monogenica-definicao-etiologia-e-mais\/\">Resumo sobre Diabetes Monog&ecirc;nica: defini&ccedil;&atilde;o, etiologia e mais!<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/med.estrategia.com\/portal\/conteudos-gratis\/doencas\/resumo-de-diabetes-mellitus-tipo-1-diagnostico-tratamento-e-mais\/\">Resumo de diabetes mellitus tipo 1: diagn&oacute;stico, tratamento e mais!<\/a>&nbsp;<\/li>\n\n\n\n<li><a href=\"https:\/\/med.estrategia.com\/portal\/conteudos-gratis\/doencas\/resumo-sobre-liraglutida-indicacoes-farmacologia-e-mais\/\">Resumo sobre liraglutida: indica&ccedil;&otilde;es, farmacologia e mais!<\/a>&nbsp;<\/li>\n\n\n\n<li><a href=\"https:\/\/med.estrategia.com\/portal\/conteudos-gratis\/doencas\/resumo-de-cetoacidose-diabetica-diagnostico-tratamento-e-mais\/\">Resumo de cetoacidose diab&eacute;tica: diagn&oacute;stico, tratamento e mais!<\/a><\/li>\n<\/ul><h3 class=\"wp-block-heading\" id=\"h-canal-do-youtube-nbsp\">Canal do YouTube&nbsp;<\/h3><ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.youtube.com\/@EstrategiaMED\" target=\"_blank\" rel=\"noopener noreferrer\">YouTube do Estrat&eacute;gia MED<\/a><\/li>\n<\/ul><h3 class=\"wp-block-heading\" id=\"h-referencias-bibliograficas-nbsp\">Refer&ecirc;ncias bibliogr&aacute;ficas&nbsp;<\/h3><ol class=\"wp-block-list\">\n<li>NIETO-MARTINEZ, R.; BARENGO, N. C.; RESTREPO, M. et al. Large scale application of the Finnish Diabetes Risk Score in Latin American and Caribbean populations: a descriptive study. <strong>Frontiers in Endocrinology<\/strong>, 2023.<\/li>\n<\/ol><ol start=\"2\" class=\"wp-block-list\">\n<li>TANKOVA, T.; CHAKAROVA, N.; ATANASSOVA, I.; DAKOVSKA, L. Evaluation of the Finnish Diabetes Risk Score as a screening tool for impaired fasting glucose, impaired glucose tolerance and undetected diabetes. <strong>Diabetes Research and Clinical Practice<\/strong>, 2011.<\/li>\n<\/ol><ol start=\"3\" class=\"wp-block-list\">\n<li>GABRIEL, R.; ACOSTA, T.; FLOREZ, K. et al. Validation of the Finnish Type 2 Diabetes Risk Score (FINDRISC) with the OGTT in health care practices in Europe. <strong>Diabetes Research and Clinical Practice<\/strong>, 2021.<\/li>\n<\/ol><\/p>\n","protected":false},"excerpt":{"rendered":"Ol&aacute;, querido doutor e doutora! O Finnish Diabetes Risk Score (FINDRISC) &eacute; um instrumento cl&iacute;nico utilizado para estimar&hellip;\n","protected":false},"author":46,"featured_media":108338,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"wl_entities_gutenberg":"","footnotes":""},"categories":[305],"tags":[1657],"wl_entity_type":[199],"class_list":{"0":"post-108337","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-exames","8":"tag-questionario-findrisc","9":"wl_entity_type-article"},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.6 (Yoast SEO v26.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Resumo do Question\u00e1rio FINDRISC: crit\u00e9rios e mais!<\/title>\n<meta name=\"description\" content=\"O FINDRISC \u00e9 um question\u00e1rio validado utilizado para estimar o risco de desenvolvimento de diabetes mellitus tipo 2 em adultos.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/med.estrategia.com\/portal\/conteudos-gratis\/exames\/resumo-do-questionario-findrisc-criterios-e-mais\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Resumo do Question\u00e1rio FINDRISC: crit\u00e9rios e mais!\" \/>\n<meta property=\"og:description\" content=\"O FINDRISC \u00e9 um question\u00e1rio validado utilizado para estimar o risco de desenvolvimento de diabetes mellitus tipo 2 em adultos.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/med.estrategia.com\/portal\/conteudos-gratis\/exames\/resumo-do-questionario-findrisc-criterios-e-mais\/\" \/>\n<meta property=\"og:site_name\" content=\"Estrat\u00e9gia MED\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/estrategiamed1\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-14T14:37:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-15T21:31:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2026\/03\/iScreen-Shoter-Google-Chrome-260314113542.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1592\" \/>\n\t<meta property=\"og:image:height\" content=\"1067\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pablo Fernandes\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@estrategiamed_\" \/>\n<meta name=\"twitter:site\" content=\"@estrategiamed_\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pablo Fernandes\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/med.estrategia.com\/portal\/conteudos-gratis\/exames\/resumo-do-questionario-findrisc-criterios-e-mais\/\",\"url\":\"https:\/\/med.estrategia.com\/portal\/conteudos-gratis\/exames\/resumo-do-questionario-findrisc-criterios-e-mais\/\",\"name\":\"Resumo do Question\u00e1rio FINDRISC: crit\u00e9rios e mais!\",\"isPartOf\":{\"@id\":\"https:\/\/med.estrategia.com\/portal\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/med.estrategia.com\/portal\/conteudos-gratis\/exames\/resumo-do-questionario-findrisc-criterios-e-mais\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/med.estrategia.com\/portal\/conteudos-gratis\/exames\/resumo-do-questionario-findrisc-criterios-e-mais\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2026\/03\/iScreen-Shoter-Google-Chrome-260314113542.jpg\",\"datePublished\":\"2026-03-14T14:37:58+00:00\",\"dateModified\":\"2026-03-15T21:31:57+00:00\",\"author\":{\"@id\":\"https:\/\/med.estrategia.com\/portal\/#\/schema\/person\/67a72aa9c51ed5919796767d808606b4\"},\"description\":\"O FINDRISC \u00e9 um question\u00e1rio validado utilizado para estimar o risco de desenvolvimento de diabetes mellitus tipo 2 em adultos.\",\"breadcrumb\":{\"@id\":\"https:\/\/med.estrategia.com\/portal\/conteudos-gratis\/exames\/resumo-do-questionario-findrisc-criterios-e-mais\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/med.estrategia.com\/portal\/conteudos-gratis\/exames\/resumo-do-questionario-findrisc-criterios-e-mais\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/med.estrategia.com\/portal\/conteudos-gratis\/exames\/resumo-do-questionario-findrisc-criterios-e-mais\/#primaryimage\",\"url\":\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2026\/03\/iScreen-Shoter-Google-Chrome-260314113542.jpg\",\"contentUrl\":\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2026\/03\/iScreen-Shoter-Google-Chrome-260314113542.jpg\",\"width\":1592,\"height\":1067},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/med.estrategia.com\/portal\/conteudos-gratis\/exames\/resumo-do-questionario-findrisc-criterios-e-mais\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/med.estrategia.com\/portal\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Conte\u00fados Gr\u00e1tis\",\"item\":\"https:\/\/med.estrategia.com\/portal\/conteudos-gratis\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Exames\",\"item\":\"https:\/\/med.estrategia.com\/portal\/conteudos-gratis\/exames\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Resumo do Question\u00e1rio FINDRISC: crit\u00e9rios e mais!\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/med.estrategia.com\/portal\/#website\",\"url\":\"https:\/\/med.estrategia.com\/portal\/\",\"name\":\"Estrat\u00e9gia MED\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/med.estrategia.com\/portal\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/med.estrategia.com\/portal\/#\/schema\/person\/67a72aa9c51ed5919796767d808606b4\",\"name\":\"Pablo Fernandes\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/med.estrategia.com\/portal\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2025\/07\/DSC_0059-1-150x150.jpg\",\"contentUrl\":\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2025\/07\/DSC_0059-1-150x150.jpg\",\"caption\":\"Pablo Fernandes\"},\"description\":\"R1 em Medicina de Fam\u00edlia e Comunidade, mineiro e apaixonado por Jesus.\",\"sameAs\":[\"https:\/\/www.instagram.com\/pablowiil\/\"],\"url\":\"https:\/\/med.estrategia.com\/portal\/author\/pablo-souza\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Resumo do Question\u00e1rio FINDRISC: crit\u00e9rios e mais!","description":"O FINDRISC \u00e9 um question\u00e1rio validado utilizado para estimar o risco de desenvolvimento de diabetes mellitus tipo 2 em adultos.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/med.estrategia.com\/portal\/conteudos-gratis\/exames\/resumo-do-questionario-findrisc-criterios-e-mais\/","og_locale":"pt_BR","og_type":"article","og_title":"Resumo do Question\u00e1rio FINDRISC: crit\u00e9rios e mais!","og_description":"O FINDRISC \u00e9 um question\u00e1rio validado utilizado para estimar o risco de desenvolvimento de diabetes mellitus tipo 2 em adultos.","og_url":"https:\/\/med.estrategia.com\/portal\/conteudos-gratis\/exames\/resumo-do-questionario-findrisc-criterios-e-mais\/","og_site_name":"Estrat\u00e9gia MED","article_publisher":"https:\/\/www.facebook.com\/estrategiamed1","article_published_time":"2026-03-14T14:37:58+00:00","article_modified_time":"2026-03-15T21:31:57+00:00","og_image":[{"width":1592,"height":1067,"url":"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2026\/03\/iScreen-Shoter-Google-Chrome-260314113542.jpg","type":"image\/jpeg"}],"author":"Pablo Fernandes","twitter_card":"summary_large_image","twitter_creator":"@estrategiamed_","twitter_site":"@estrategiamed_","twitter_misc":{"Escrito por":"Pablo Fernandes","Est. tempo de leitura":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/med.estrategia.com\/portal\/conteudos-gratis\/exames\/resumo-do-questionario-findrisc-criterios-e-mais\/","url":"https:\/\/med.estrategia.com\/portal\/conteudos-gratis\/exames\/resumo-do-questionario-findrisc-criterios-e-mais\/","name":"Resumo do Question\u00e1rio FINDRISC: crit\u00e9rios e mais!","isPartOf":{"@id":"https:\/\/med.estrategia.com\/portal\/#website"},"primaryImageOfPage":{"@id":"https:\/\/med.estrategia.com\/portal\/conteudos-gratis\/exames\/resumo-do-questionario-findrisc-criterios-e-mais\/#primaryimage"},"image":{"@id":"https:\/\/med.estrategia.com\/portal\/conteudos-gratis\/exames\/resumo-do-questionario-findrisc-criterios-e-mais\/#primaryimage"},"thumbnailUrl":"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2026\/03\/iScreen-Shoter-Google-Chrome-260314113542.jpg","datePublished":"2026-03-14T14:37:58+00:00","dateModified":"2026-03-15T21:31:57+00:00","author":{"@id":"https:\/\/med.estrategia.com\/portal\/#\/schema\/person\/67a72aa9c51ed5919796767d808606b4"},"description":"O FINDRISC \u00e9 um question\u00e1rio validado utilizado para estimar o risco de desenvolvimento de diabetes mellitus tipo 2 em adultos.","breadcrumb":{"@id":"https:\/\/med.estrategia.com\/portal\/conteudos-gratis\/exames\/resumo-do-questionario-findrisc-criterios-e-mais\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/med.estrategia.com\/portal\/conteudos-gratis\/exames\/resumo-do-questionario-findrisc-criterios-e-mais\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/med.estrategia.com\/portal\/conteudos-gratis\/exames\/resumo-do-questionario-findrisc-criterios-e-mais\/#primaryimage","url":"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2026\/03\/iScreen-Shoter-Google-Chrome-260314113542.jpg","contentUrl":"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2026\/03\/iScreen-Shoter-Google-Chrome-260314113542.jpg","width":1592,"height":1067},{"@type":"BreadcrumbList","@id":"https:\/\/med.estrategia.com\/portal\/conteudos-gratis\/exames\/resumo-do-questionario-findrisc-criterios-e-mais\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/med.estrategia.com\/portal\/"},{"@type":"ListItem","position":2,"name":"Conte\u00fados Gr\u00e1tis","item":"https:\/\/med.estrategia.com\/portal\/conteudos-gratis\/"},{"@type":"ListItem","position":3,"name":"Exames","item":"https:\/\/med.estrategia.com\/portal\/conteudos-gratis\/exames\/"},{"@type":"ListItem","position":4,"name":"Resumo do Question\u00e1rio FINDRISC: crit\u00e9rios e mais!"}]},{"@type":"WebSite","@id":"https:\/\/med.estrategia.com\/portal\/#website","url":"https:\/\/med.estrategia.com\/portal\/","name":"Estrat\u00e9gia MED","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/med.estrategia.com\/portal\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Person","@id":"https:\/\/med.estrategia.com\/portal\/#\/schema\/person\/67a72aa9c51ed5919796767d808606b4","name":"Pablo Fernandes","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/med.estrategia.com\/portal\/#\/schema\/person\/image\/","url":"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2025\/07\/DSC_0059-1-150x150.jpg","contentUrl":"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2025\/07\/DSC_0059-1-150x150.jpg","caption":"Pablo Fernandes"},"description":"R1 em Medicina de Fam\u00edlia e Comunidade, mineiro e apaixonado por Jesus.","sameAs":["https:\/\/www.instagram.com\/pablowiil\/"],"url":"https:\/\/med.estrategia.com\/portal\/author\/pablo-souza\/"}]}},"_wl_alt_label":[],"wl:entity_url":"\/post\/resumo-do-questionario-findrisc-criterios-e-mais-108337","_links":{"self":[{"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/posts\/108337","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/users\/46"}],"replies":[{"embeddable":true,"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/comments?post=108337"}],"version-history":[{"count":3,"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/posts\/108337\/revisions"}],"predecessor-version":[{"id":108359,"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/posts\/108337\/revisions\/108359"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/media\/108338"}],"wp:attachment":[{"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/media?parent=108337"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/categories?post=108337"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/tags?post=108337"},{"taxonomy":"wl_entity_type","embeddable":true,"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/wl_entity_type?post=108337"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}